Cervantes-Apolinar María Yolanda, Guzman-Holst Adriana, Mascareñas De Los Santos Abiel, Macías Hernández Alejandro Ernesto, Cabrera Álvaro, Lara-Solares Argelia, Abud Mendoza Carlos, Motola Kuba Daniel, Flores Díaz Diana Fabiola, Salgado Gomez Fernanda, Castro-Narro Graciela Elia, Nieto Javier, Mata-Marín José Antonio, Barba Gómez José Fernando, Tinoco Juan Carlos, Calleja Castillo Juan Manuel, Contreras Serratos Maria Margarita, Castellanos Ramos Nathali, Rosas Carrasco Oscar, Ricaño Raúl, Huerta García Gloria C
GSK México, Torre Mitikah Piso 19 y 20, Circuito Interior Avenida Río Churubusco 601, Col. Xoco. Alc. Benito Juárez, Mexico City 03330, Mexico.
University Hospital Monterrey, Monterrey 64460, Mexico.
Vaccines (Basel). 2024 Dec 21;12(12):1441. doi: 10.3390/vaccines12121441.
Herpes zoster (HZ) is a common disease in older adults and immunocompromised patients, and is frequently associated with long-term complications that impact quality of life. Fortunately, more than one vaccine against HZ is now available in Mexico. Two expert consensus groups discussed adult vaccination strategies in Mexico, focusing on HZ in older adults and immunocompromised individuals; their insights are reported here. HZ is usually treated inappropriately in Mexico. Late diagnosis and suboptimal management are common, as is a lack of treatment options, particularly for pain, which is often unresponsive to standard painkillers. Improving vaccination rates against HZ in Mexico is therefore important, but several barriers to HZ vaccination exist. It is not included in the national vaccination schedule, where included vaccines usually have higher coverage. Actions to overcome barriers include improving awareness of HZ and vaccine availability, developing and promoting guidelines and recommendations for vaccination, and expanding access and infrastructure for vaccination.
带状疱疹（HZ）是老年人和免疫功能低下患者的常见疾病，并且经常伴有影响生活质量的长期并发症。幸运的是，墨西哥现在有不止一种针对HZ的疫苗。两个专家共识小组讨论了墨西哥的成人疫苗接种策略，重点是老年人和免疫功能低下个体的HZ；他们的见解在此报告。在墨西哥，HZ的治疗通常不恰当。诊断延迟和管理欠佳很常见，治疗选择也很缺乏，尤其是对于疼痛，标准止痛药往往无效。因此，提高墨西哥针对HZ的疫苗接种率很重要，但HZ疫苗接种存在几个障碍。它未被纳入国家疫苗接种计划，而纳入该计划的疫苗通常覆盖率更高。克服障碍的行动包括提高对HZ和疫苗可及性的认识，制定和推广疫苗接种指南及建议，以及扩大疫苗接种的可及性和基础设施。
